Mary Napier is in the Cancer Genetics Team at Agilent Technologies where she manages products that range from arrays to NGS panels for Cancer. Within her role she manages collaborations worldwide.
She received her MBA from the University of Chicago in finance and entrepreneurship. Directly out of business school Mary worked at a Private Equity Fund of Funds as an assistant portfolio manager. The portfolio was close to $100M of indirect and direct investments across a broad range of industries.
She is currently on the board of Berkeley Biolabs. Previously she held a board position for six years at SFMoMA’s contemporary art group: SECA.